The empty auditoriums, Gila monsters, resistant pharmaceutical executives and enigmas that led to Ozempic and other drugs that may change how society thinks about obesity.
Human research trials at the New York State Psychiatric Institute at Columbia have been paused while regulators review whether protocols were violated.